Related Experiment Video
Updated: Jan 14, 2026
06:27
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
3.1K
Sustained low-efficiency dialysis in congested patients with advanced heart failure
Cardiorenal Medicine
|October 21, 2025
Summary
Sustained low-efficiency dialysis (SLED) significantly reduced heart failure hospitalizations and improved medication management in patients with advanced heart failure. This approach also led to prolonged survival compared to standard medical therapy alone.
Area of Science:
- Cardiology
- Nephrology
- Critical Care Medicine
Background:
- Advanced heart failure often presents with persistent congestion and renal dysfunction.
- Palliative care is a common approach for patients unsuitable for advanced therapies.
- Sustained low-efficiency dialysis (SLED) offers a potential alternative for managing fluid overload in these patients.
Purpose of the Study:
- To evaluate the efficacy of SLED as an alternative to palliative care in advanced heart failure patients with persistent congestion.
- To compare hospitalization rates, medication use, and survival between SLED and standard therapy.
Main Methods:
- A single-center, non-randomized retrospective cohort study included 139 patients with advanced heart failure and renal dysfunction.
- Patients were divided into SLED (n=107) and standard therapy (n=32) groups.
- Outcomes assessed included hospitalizations, medication use, and mortality one year pre- and post-index date.
Main Results:
- SLED patients experienced a significant reduction in heart failure hospitalizations (13% vs. 78%) and hospital stay duration.
- All-cause hospital stay duration was reduced in the SLED group, with no change in rates.
- SLED improved the use of guideline-directed medical therapy and significantly prolonged median survival (23 vs. 3 months).
Conclusions:
- SLED is associated with fewer heart failure hospitalizations in advanced heart failure patients.
- SLED facilitates optimization of pharmacological heart failure therapy.
- SLED offers a survival benefit compared to standard therapy alone in this patient population.
Related Concept Videos
01:27Dialysis
1.2K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.2K
01:15Dialysis
1.6K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.6K
01:22Heart Failure VI: Adjunct Therapies
252
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
252
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
526
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
526
01:24Hemodialysis II: Procedure and Complications
635
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
635
01:22Heart Failure Drugs: Diuretics
796
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
796